SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Jolles, J. S. Orange, A. Gardulf, M. R. Stein, R. Shapiro, M. Borte, M. Berger, Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease, Clinical & Experimental Immunology, 2015, 179, 2
  2. 2
    Andrew C. Issekutz, Derek Rowter, Sylvia Miescher, Fabian Käsermann, Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells, Clinical Immunology, 2015, 160, 2, 123

    CrossRef

  3. 3
    M. Elizabeth M. Younger, William Blouin, Carla Duff, Kristin Buehler Epland, Elyse Murphy, Debra Sedlak, Subcutaneous Immunoglobulin Replacement Therapy, Journal of Infusion Nursing, 2015, 38, 1, 70

    CrossRef

  4. 4
    S. Jolles, R. Borrell, S. Zouwail, A. Heaps, H. Sharp, M. Moody, C. Selwood, P. Williams, C. Phillips, K. Hood, S. Holding, T. El Shanawany, Calculated globulin (CG) as a screening test for antibody deficiency, Clinical & Experimental Immunology, 2014, 177, 3
  5. 5
    Richard L Wasserman, Hizentra for the treatment of primary immunodeficiency, Expert Review of Clinical Immunology, 2014, 10, 10, 1293

    CrossRef

  6. 6
    Helen Chapel, Ann Gardulf, Subcutaneous immunoglobulin replacement therapy, Current Opinion in Allergy and Clinical Immunology, 2013, 13, 6, 623

    CrossRef

  7. 7
    Stephen Jolles, The Variable in Common Variable Immunodeficiency: A Disease of Complex Phenotypes, The Journal of Allergy and Clinical Immunology: In Practice, 2013, 1, 6, 545

    CrossRef